LogicBio Therapeutics Stock Forecast - Double Exponential Smoothing
| LOGCDelisted Stock | USD 2.07 0.00 0.00% |
The Double Exponential Smoothing forecasted value of LogicBio Therapeutics on the next trading day is expected to be 2.06 with a mean absolute deviation of 0.04 and the sum of the absolute errors of 2.43. LogicBio Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast LogicBio Therapeutics stock prices and determine the direction of LogicBio Therapeutics's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of LogicBio Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. LogicBio |
Most investors in LogicBio Therapeutics cannot accurately predict what will happen the next trading day because, historically, stock markets tend to be unpredictable and even illogical. Modeling turbulent structures requires applying different statistical methods, techniques, and algorithms to find hidden data structures or patterns within the LogicBio Therapeutics' time series price data and predict how it will affect future prices. One of these methodologies is forecasting, which interprets LogicBio Therapeutics' price structures and extracts relationships that further increase the generated results' accuracy.
Double exponential smoothing - also known as Holt exponential smoothing is a refinement of the popular simple exponential smoothing model with an additional trending component. Double exponential smoothing model for LogicBio Therapeutics works best with periods where there are trends or seasonality. LogicBio Therapeutics Double Exponential Smoothing Price Forecast For the 20th of April
Given 90 days horizon, the Double Exponential Smoothing forecasted value of LogicBio Therapeutics on the next trading day is expected to be 2.06 with a mean absolute deviation of 0.04, mean absolute percentage error of 0.05, and the sum of the absolute errors of 2.43.Please note that although there have been many attempts to predict LogicBio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that LogicBio Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
LogicBio Therapeutics Stock Forecast Pattern
| Backtest LogicBio Therapeutics | LogicBio Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of LogicBio Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent LogicBio Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | -0.0388 |
| MAD | Mean absolute deviation | 0.0412 |
| MAPE | Mean absolute percentage error | 0.0322 |
| SAE | Sum of the absolute errors | 2.43 |
Predictive Modules for LogicBio Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as LogicBio Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of LogicBio Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
LogicBio Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with LogicBio Therapeutics stock to make a market-neutral strategy. Peer analysis of LogicBio Therapeutics could also be used in its relative valuation, which is a method of valuing LogicBio Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
LogicBio Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how LogicBio Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading LogicBio Therapeutics shares will generate the highest return on investment. By undertsting and applying LogicBio Therapeutics stock market strength indicators, traders can identify LogicBio Therapeutics entry and exit signals to maximize returns.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards LogicBio Therapeutics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, LogicBio Therapeutics' short interest history, or implied volatility extrapolated from LogicBio Therapeutics options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in price. Note that the LogicBio Therapeutics information on this page should be used as a complementary analysis to other LogicBio Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Consideration for investing in LogicBio Stock
If you are still planning to invest in LogicBio Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the LogicBio Therapeutics' history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |